Ask AI
H.R. 5723

Expanding Oversight of Opioid Prescribing and Payment Act of 2018

Expanding Oversight of Opioid Prescribing and Payment Act of 2018

(Sec. 2) This bill requires the Medicare Payment Advisory Commission to report to Congress on: (1) how Medicare pays for opioid and non-opioid pain management treatments in inpatient and outpatient hospital settings; (2) current incentives for prescribing opioid and non-opioid treatments under Medicare inpatient and outpatient prospective payment systems, along with recommendations to address any identified adverse incentives; and (3) how opioid use is currently tracked and monitored through Medicare and any areas for improvement.

Received in the Senate and Read twice and referred to the Committee on Finance.

Rep. Tenney, Claudia [R-NY-22](R-NY)Sponsor
4 cosponsors1 D3 R
4cosponsors3committees19actions1related bills8subjects
  1. IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Finance.

    Finance Committee
  2. FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  3. FloorH37300

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5264)

  4. Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5264)

  5. FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 5723.

  6. FloorH30000

    Considered under suspension of the rules. (consideration: CR H5264-5265)

  7. FloorH30300

    Mr. Roskam moved to suspend the rules and pass the bill, as amended.

  8. CalendarsH12410

    Placed on the Union Calendar, Calendar No. 592.

  9. DischargeH12300

    Committee on Energy and Commerce discharged.

    Energy and Commerce Committee
  10. Committee5500

    Committee on Energy and Commerce discharged.

    Energy and Commerce Committee
  11. CommitteeH12200

    Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-760, Part I.

    Ways and Means Committee
  12. Committee5000

    Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-760, Part I.

    Ways and Means Committee
  13. Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  14. Committee

    Ordered to be Reported (Amended) by Voice Vote.

    Ways and Means Committee
  15. Committee

    Committee Consideration and Mark-up Session Held.

    Ways and Means Committee
  16. IntroReferralH11100

    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Energy and Commerce Committee
  17. IntroReferralH11100

    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Ways and Means Committee
  18. IntroReferralIntro-H

    Introduced in House

  19. IntroReferral1000

    Introduced in House

Jun 19, 201836

Expanding Oversight of Opioid Prescribing and Payment Act of 2018

(Sec. 2) This bill requires the Medicare Payment Advisory Commission to report to Congress on: (1) how Medicare pays for opioid and non-opioid pain management treatments in inpatient and outpatient hospital settings; (2) current incentives for prescribing opioid and non-opioid treatments under Medicare inpatient and outpatient prospective payment systems, along with recommendations to address any identified adverse incentives; and (3) how opioid use is currently tracked and monitored through Medicare and any areas for improvement.

May 9, 2018

Expanding Oversight of Opioid Prescribing and Payment Act of 2018

This bill requires the Medicare Payment Advisory Commission to report to Congress on: (1) how Medicare pays for opioid and non-opioid pain management treatments in inpatient and outpatient hospital settings; (2) current incentives for prescribing opioid and non-opioid treatments under Medicare inpatient and outpatient prospective payment systems, along with recommendations to address any identified adverse incentives; and (3) how opioid use is currently tracked and monitored through Medicare and any areas for improvement.

Expanding Oversight of Opioid Prescribing and Payment Act of 2018 — Informed